Acacia Research Corporation — 2017 Form 10-K
Reporting period: Fiscal year ended December 31, 2017. The filing also provides unaudited quarterly results, including the quarter ended December 31, 2017. Unless otherwise noted, amounts are in U.S. dollars.
Business context
Acacia’s core business is acquiring or controlling patent rights, licensing them, and pursuing infringement claims when necessary. It also began expanding strategic investments and IP-services partnerships with technology companies, including Veritone and Miso Robotics. The company reported one new patent portfolio in 2017 and 13 licensing and enforcement programs generating revenue.
Financial performance and liquidity
| Metric | 2017 | 2016 |
|---|---|---|
| Revenue | $65.4 million | $152.7 million |
| Operating loss | $27.3 million | $37.4 million |
| Net income (loss) attributable to Acacia | $22.2 million | $(54.1) million |
| Operating cash flow | $24.5 million | $34.1 million |
| Cash, cash equivalents and short-term investments | $136.6 million | $158.5 million |
| Working capital | $130.1 million | $160.3 million |
| Total liabilities | $13.1 million | $28.6 million |
Operating margin was approximately negative 42% in 2017. Net income was driven by $49.5 million of unrealized gains associated with Acacia’s Veritone investment; Acacia’s patent-licensing operations remained loss-making. Cash used in investing activities was $16.1 million, while financing activities provided $0.7 million. The company reported no long-term debt or committed credit lines. It said available resources and anticipated operating cash flows were expected to meet requirements through at least March 2019.
Acacia held a $104.8 million investment at fair value, primarily in Veritone shares and warrants. A 10% adverse change in Veritone’s share price was estimated to reduce the fair value of the Veritone equity and warrant investment by approximately $11.1 million.
Changes versus prior periods
- Revenue fell 57% from 2016, reflecting fewer agreements and lower average revenue per agreement. Agreements executed declined to 20 from 39; programs generating revenue declined to 13 from 28.
- Acacia reported net income after losses in 2016 and 2015, but the 2017 result included the substantial noncash Veritone investment gain. Operating expenses declined, including lower patent litigation costs, amortization, and general and administrative expenses.
- Patent impairment charges were $2.2 million in 2017, down from $42.3 million in 2016. Net patents declined to $61.9 million from $86.3 million.
- For the fourth quarter of 2017, revenue was $3.5 million and Acacia-attributable net loss was $110.2 million. The quarter included $103.0 million of total other expense; the filing’s annual discussion reports an annual Veritone unrealized gain, but the quarterly table does not clearly explain the full quarter-to-quarter valuation movement.
Outlook, risks and unusual items
- Outlook: No specific revenue or earnings guidance was provided. Management said it would continue monetizing existing patent assets while increasing its focus on partnerships with high-growth technology companies. It warned that ongoing difficulty sourcing quality patent portfolios could lead to further declines in licensing revenue and undermine the sustainability of that business.
- Investments and subsequent events: In February 2018, Acacia invested an additional $6.0 million in Miso Robotics, bringing its ownership to approximately 30%. In January 2018, it invested $1.0 million in Bitzumi and obtained rights and options for additional investment, subject to agreement terms. A $20 million share repurchase program was authorized in February 2018; repurchases are discretionary, not required.
- Revenue and litigation uncertainty: Revenue is irregular and depends on license agreements, litigation outcomes, appeals, and payment timing. Three licensees accounted for 54%, 21%, and 10% of 2017 revenue. Patent litigation can be costly, prolonged, and expose the company to adverse judgments, sanctions, or attorneys’ fees. Seven cases had scheduled trial dates within the following twelve months, subject to court changes.
- Investment and accounting risk: Veritone and other investees were not profitable and had limited resources. Fair-value changes can materially affect reported earnings. Patent asset valuations and impairment charges also depend on estimates of future licensing cash flows and legal outcomes.
- Taxes and contingencies: The 2017 tax law changes led to an estimated $25.3 million reduction in deferred tax assets; the company reported a full valuation allowance and no material effect on the financial statements from that revaluation. The filing disclosed $1.2 million of estimated contingency accruals, with a stated potential expense range of $1.2 million to $3.0 million. Management concluded ordinary-course legal matters were not expected to have a material effect, while noting enforcement-related sanctions could be material.
Important facts for investors to verify
- How much of 2017’s reported profit reflects realized operating performance versus noncash Veritone valuation gains, and what explains the sharp fourth-quarter valuation reversal shown in the quarterly data?
- Whether patent portfolio intake and licensing revenue can stabilize, given only one new portfolio in 2017 and the steep annual revenue decline.
- The current value, liquidity restrictions, and downside exposure of Veritone holdings, and the financial performance and funding needs of Miso Robotics and Bitzumi.
- The outcomes, timing, and potential cost of pending patent litigation, including scheduled trials, appeals, and possible sanctions or fee awards.
- Whether cash resources remain adequate as licensing receipts fluctuate and Acacia funds strategic investments or elects to repurchase shares.